Establishment of in vitro cellular model predicting histocompatibity in allograft

Abstract

A novel in vitro cellular model prodicting recipient-donor histocompatibility in allograft was developed to select the donor validly. Fifteen couples of blood samples of donor and recipient in human BMT were examined using the model, and skin allograft in mice was performed to test the model. The results showed that the less the differences of histocompatibility evaluated by the model were, the later GVHR in human BMT occurred and the longer the survival time of skin allografts in mice. It was suggested that the model could be used to predict correctly histocompatibility between donor and recipient.

Keywords

histocompatibility / allograft / model / histocompatibility

References

[1] B, 1997,26:274

[2] LacerdaJ F, LadanyiM, LouieD C, et al. . Human Epstein-Barr Viruse (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regression of autologous EBV-induced B cell lymphoproliferation in xenografted C. B-17scid/scid mice. J Exp Med, 1996, 831215-1215

[3] 1998.309

[4] 1982,2:32

[5] SimpsonE, RoopenianD, GoulmyE. Much ado about minor histocompatibility antigens. Immunology Today, 1998, 19108-108

[6] DenH J, MeadowsL, WangW, et al. . The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science, 1998, 2791054-1054

[7] BeharE, ChaoN, HirakiD, et al. . Polymorphism of adhension molecule CD31 and its role in acute graft-versushost disease. New Eng J Med, 1996, 3342826-2826